[CLDX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -28.95%
YoY- -24.63%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 3,480 685 3,786 668 236 2,728 887 148.96%
PBT -13,373 -16,538 -22,839 -14,224 -11,259 -12,625 -10,447 17.91%
Tax 382 764 -939 1,088 -228 -16 -4,448 -
NP -13,373 -16,538 -21,900 -14,224 -11,031 -12,625 -10,447 17.91%
Tax Rate - - - - - - - -
Total Cost 16,853 17,223 25,686 14,892 11,267 15,353 11,334 30.30%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -384.28 -2,414.31 -578.45 -2,129.34 -4,674.15 -462.79 -1,177.79 -52.63%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.34 -0.42 -0.55 -0.36 -0.50 -0.73 -0.64 -34.43%
EPS Diluted -0.34 -0.42 -0.55 -0.36 -0.50 -0.73 -0.64 -34.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.